LifeAgain Insurance Solutions, a wholly-owned subsidiary of Cardium Therapeutics, has signed a commercialisation agreement with insurance broker AgencyONE to support the development and marketing of new survivable risk life insurance ...
Cardium Therapeutics has filed a new 510(k) submission for its current FDA-cleared Excellagen advanced wound care product based on the company's supplemental research and development activities. The new 510(k) submission describes ...
The British Standards Institution (BSI) has granted ISO 13485:2003 certification to Cardium Therapeutics' Excellagen advanced wound care gel product. Excellagen, which is designed for application at only one-week intervals, is a fibrillar ...
Cardium Therapeutics and its Tissue Repair Company, Cardium, will utilize AMRI's Burlington, US, site to manufacture sterile pre-filled syringes in support of the US introduction of Excellagen, as per the signed contract agreement. ...
Tags: Cardium Therapeutics, syringe-based, pre-filled syringes